These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 21557558)

  • 1. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
    Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
    Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen.
    Jain AK; Swarnakar NK; Godugu C; Singh RP; Jain S
    Biomaterials; 2011 Jan; 32(2):503-15. PubMed ID: 20934747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes).
    Jain S; Patil SR; Swarnakar NK; Agrawal AK
    Mol Pharm; 2012 Sep; 9(9):2626-35. PubMed ID: 22871060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity.
    Jain AK; Thanki K; Jain S
    Mol Pharm; 2013 Sep; 10(9):3459-74. PubMed ID: 23927416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
    Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
    ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of surfactants on the properties of PLGA nanoparticles.
    Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
    J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation.
    Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z
    Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats.
    Ammar el-SM; Said SA; Suddek GM; El-Damarawy SL
    Can J Physiol Pharmacol; 2011 Apr; 89(4):269-76. PubMed ID: 21526973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M; Nafee N; Saad H; Kazem A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
    Upadhyay KK; Bhatt AN; Mishra AK; Dwarakanath BS; Jain S; Schatz C; Le Meins JF; Farooque A; Chandraiah G; Jain AK; Misra A; Lecommandoux S
    Biomaterials; 2010 Apr; 31(10):2882-92. PubMed ID: 20053435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
    Lin R; Shi Ng L; Wang CH
    Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
    Misra R; Sahoo SK
    Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.